Qeios
 | |
Type of site | Science |
|---|---|
| Available in | English |
| CEO | Gabriele Marinello |
| URL | www |
| Launched | April 11, 2019 |
| Current status | Online |
| ISSN | 2632-3834 |
Qeios (pronounced "chaos") is a multidisciplinary open-access, open peer review, scientific publishing platform for preprints and final articles.[1] Researchers can post their research papers for discussion,[2][3] which takes the place of formal editors.[2] Qeios does not charge any fees to authors, and all content is free to end users as well.[4][3] Articles post within minutes.[5][4] Qeios is among the few platforms that allow the open peer review of preprints, and is among those with the higher number of preprint peer reviews performed and registered as such at Crossref.[6]
Qeios seeks to serve as a better rating system for research and reduce bias and censorship by eliminating editorial gatekeeping and pre-publication peer review.[1][2] The platform also seeks to avoid inconclusive findings by ensuring that terms used in articles are linked to established definitions.[7] The platform uses artificial intelligence to recruit reviewers with expertise relevant to each article's subject matter.[2] Reviewers' names, their reviews, and article changes are posted for all to see and comment on.[2][5][3] Contributors are expected to disclose any conflicts of interest.[3]
Qeios has published articles by researchers from California Institute of Technology, University of Cambridge, Harvard, Stanford, and University College London, among others.[1] Some researchers use Qeios as the final destination for their work, others use it as a preprint service ahead of publication in a journal.[1] Qeios is a member of ORCID and Crossref.[5][3] It is indexed on Google Scholar, applying to be indexed by PubMed and Web of Science, and is archived in Portico and the British Library.[2] Qeios is tracked in the National Institutes of Health's iSearch COVID-19 portfolio.[8] It is a signatory to Declaration on Research Assessment (DORA) and ASAPbio's Publish Your Reviews.[9][10] It is a partner with AfricArXiv, a digital archive for African research.[11]
History
Qeios was co-founded by Gabriele Marinello and started in 2019.[1] In 2019, the Open Education Consortium named Qeios as the recipient of its Award for Excellence.[1]
Advisory board
There are 22 members of the Qeios advisory board:
- Arindam Basu, University of Canterbury, New Zealand
- Alberto Bedogni, University of Padua, Italy
- Giorgio Bedogni, University of Bologna, Italy
- Indranath Chatterjee, Tongmyong University, South Korea
- Sharon Cox, University College London, UK
- Konstantinos Farsalinos, University of West Attica, Greece
- Elena Giglia, University of Turin, Italy
- Joe G. Gitchell, Pinney Associates, US
- Michele Filannino, Massachusetts Institute of Technology, US
- Janna Hastings, University College London, UK
- Paola Masuzzo, IGDORE, Belgium
- Ramuntcho Matta, Lizières, France
- Susan Michie, University College London, UK
- Mike Morrison, Michigan State University, US
- Peter Muennig, Columbia University, US
- Rita Nocerino, University of Naples Federico II, Italy
- Silvio Peroni, University of Bologna, Italy
- Olga Perski, University College London, UK
- Dylan Roskams-Edris, McGill University, Canada
- Vassilis Sideropoulos, University College London, UK
- David Simons, Royal Veterinary College, UK
- Robert West, University College London, UK
Notes
- ^ a b c d e f Coy, Peter (2022-01-28). "Opinion | How to Disseminate Science Quickly". The New York Times. ISSN 0362-4331. Retrieved 2022-09-30.
- ^ a b c d e f "Blog | A faster, high-quality process for scientific research approval". Alley Oop (in Italian). 2022-09-06. Retrieved 2022-09-30.
- ^ a b c d e "Posting Policy | Qeios". www.qeios.com. Retrieved 2022-09-30.
- ^ a b "Order within disorder". www.linkedin.com. Retrieved 2022-09-30.
- ^ a b c "New Journal Seeks to Reduce Bias in Scientific Publishing | Columbia Public Health". www.publichealth.columbia.edu. Retrieved 2022-09-30.
- ^ "The growth of open peer review". www.leidenmadtrics.nl. Retrieved 2022-09-30.
- ^ West, Robert (2020-07-01). "Addiction 's policy on preprints". Addiction. 115 (7): 1206. doi:10.1111/add.15063. ISSN 0965-2140. PMID 32198785. S2CID 214599950.
- ^ "Welcome to the COVID-19 Portfolio". icite.od.nih.gov. Retrieved 2022-09-30.
- ^ "Signers". DORA. Retrieved 2022-09-30.
- ^ "Publish Your Reviews". ASAPbio. Retrieved 2022-09-30.
- ^ "Partners – AfricArXiv". Retrieved 2022-09-30.